Lilly's Omvoh shows sustained 4-year efficacy in ulcerative colitis
PositiveFinancial Markets

Lilly's Omvoh has demonstrated impressive sustained efficacy over four years in treating ulcerative colitis, a chronic inflammatory bowel disease. This is significant as it offers hope for patients seeking long-term relief from their symptoms and improves their quality of life. The results from the clinical trial highlight the potential of Omvoh as a reliable treatment option, marking a notable advancement in the management of this challenging condition.
— Curated by the World Pulse Now AI Editorial System